Nektar’s Rezpegaldesleukin Shows Efficacy in Phase 2b Atopic Dermatitis Trial

A new medicine, rezpegaldesleukin, shows promise for moderate-to-severe eczema. It boosts special immune cells to rebalance the body and cut inflammation, leading to rapid and deeper symptom relief. It's an FDA Fast Tracked, self-injected treatment.